4 results
The AlphaCore* is currently being used in some hospitalised COPD subjects, as adjunctive treatment to regular care. This use is conform CE and is showing diminished breathlessness in some subjects. For further investigation of these results, this…
The aim of the follow-up study is to determine the differences between early versus late treatment with GZ / SAR402671 in the effect on total kidney volume growth (total kidney volume, TKV) and in the effect on slowing down renal impairment (change…
To establish the accuracy of the Medtrum TouchCare Nano 14 CGM system compared to thecurrent gold standards i.e. established central laboratory technique (the StatStrip Xpress®monitoring system (Nova Biomedical, Waltham, WA), the accuracy of a…
To establish the performance of the TouchCare Nano 14 CGM system among persons with DM.